Novel therapeutics for schizophrenia: targeting glycine modulation of NMDA glutamate receptors.
Stahl
Stephen M
SM
Department of Psychiatry, University of California-San Diego, La Jolla, CA, USA.
D026905:Amino Acid Transport Systems / Q000096:biosynthesis / Q000187:drug effects / Q000378:metabolism; D014150:Antipsychotic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D005998:Glycine / Q000502:physiology*; D018684:Glycine Agents / Q000494:pharmacology*; D006801:Humans; D016194:Receptors, N-Methyl-D-Aspartate / Q000187:drug effects*; D012559:Schizophrenia / Q000188:drug therapy*; D012694:Serine / Q000378:metabolism
D026905:Amino Acid Transport Systems; D014150:Antipsychotic Agents; D018684:Glycine Agents; D016194:Receptors, N-Methyl-D-Aspartate; D012694:Serine; D005998:Glycine